Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.

Lin CH, Chen CC, Wang FC, Lane HY.

Psychiatry Clin Neurosci. 2013 May;67(4):265-72. doi: 10.1111/pcn.12046.

2.

Early prediction of fluoxetine response for Han Chinese inpatients with major depressive disorder.

Lin CH, Lane HY, Chen CC, Juo SH, Yen CF.

J Clin Psychopharmacol. 2011 Apr;31(2):187-93. doi: 10.1097/JCP.0b013e318210856f. Erratum in: J Clin Psychopharmacol. 2011 Dec;31(6):716.

PMID:
21346612
3.

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.

J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.

PMID:
19027961
4.

The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.

Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE.

Int Clin Psychopharmacol. 2005 Mar;20(2):87-91.

PMID:
15729083
6.

Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.

Lin CH, Lane HY, Chen CC, Juo SH, Yen CF.

Psychiatry Clin Neurosci. 2011 Aug;65(5):510-7. doi: 10.1111/j.1440-1819.2011.02235.x.

7.

Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients.

Katoh Y, Uchida S, Kawai M, Takei N, Mori N, Kawakami J, Kagawa Y, Yamada S, Namiki N, Hashimoto H.

Biol Pharm Bull. 2010;33(12):1999-2002.

8.

Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission.

Zimmerman M, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA.

J Affect Disord. 2012 Dec 15;142(1-3):77-81. doi: 10.1016/j.jad.2012.03.044. Epub 2012 Sep 12.

PMID:
22980402
9.

Clinical differences between early and late remission in depressive patients.

Roca M, García-Toro M, García-Campayo J, Vives M, Armengol S, García-García M, Asensio D, Gili M.

J Affect Disord. 2011 Nov;134(1-3):235-41. doi: 10.1016/j.jad.2011.05.051. Epub 2011 Jun 14.

PMID:
21676465
10.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
11.

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

Tadić A, Helmreich I, Mergl R, Hautzinger M, Kohnen R, Henkel V, Hegerl U.

J Affect Disord. 2010 Jan;120(1-3):86-93. doi: 10.1016/j.jad.2009.04.014.

PMID:
19428118
12.

Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.

Lin CH, Chen MC, Yang WC, Lane HY.

Eur Neuropsychopharmacol. 2016 Feb;26(2):225-33. doi: 10.1016/j.euroneuro.2015.12.019. Epub 2015 Dec 11.

PMID:
26718791
13.

Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.

van Calker D, Zobel I, Dykierek P, Deimel CM, Kech S, Lieb K, Berger M, Schramm E.

J Affect Disord. 2009 Apr;114(1-3):243-53. doi: 10.1016/j.jad.2008.07.023. Epub 2008 Oct 11.

PMID:
18849079
14.

Early symptom change prediction of remission in depression treatment.

Katz MM, Meyers AL, Prakash A, Gaynor PJ, Houston JP.

Psychopharmacol Bull. 2009;42(1):94-107.

PMID:
19204654
15.

Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD).

Ballesteros J, Bobes J, Bulbena A, Luque A, Dal-Ré R, Ibarra N, Güemes I.

J Affect Disord. 2007 Sep;102(1-3):93-9. Epub 2007 Jan 26.

PMID:
17258323
16.

Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.

Helmreich I, Wagner S, König J, Kohnen R, Szegedi A, Hiemke C, Tadić A.

J Affect Disord. 2015 Apr 1;175:199-208. doi: 10.1016/j.jad.2014.12.043. Epub 2014 Dec 24.

PMID:
25638793
17.

Severity classification on the Hamilton Depression Rating Scale.

Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K.

J Affect Disord. 2013 Sep 5;150(2):384-8. doi: 10.1016/j.jad.2013.04.028. Epub 2013 Jun 4.

PMID:
23759278
19.

Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.

Nelson JC, Zhang Q, Deberdt W, Marangell LB, Karamustafalioglu O, Lipkovich IA.

Curr Med Res Opin. 2012 Mar;28(3):325-34. doi: 10.1185/03007995.2011.654010. Epub 2012 Jan 31.

PMID:
22292447
20.

Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.

Leinonen E, Lepola U, Koponen H, Mehtonen OP, Rimon R.

Acta Psychiatr Scand. 1997 Dec;96(6):497-504.

PMID:
9421348

Supplemental Content

Support Center